Clinical microbicide research: An overview

Tropical Medicine and International Health

Volumn 9, Issue 12, 2004, Pages 1290-1296

  Van Damme, Lut ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Female controlled; Microbicides; Nonoxynol 9; Randomised clinical trials; Women

Indexed keywords

ACIDFORM; ADVANTAGE S; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; BENZALKONIUM CHLORIDE; CARBOPOL 974P; CARRAGEENAN; CELLULOSE SULFATE; CHLORHEXIDINE; COL 1492; DAPIVIRINE; DETERGENT; EMMELLE; GLYCEROL; MENFEGOL; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONOXINOL 9; PRO 2000; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAVVY; SPERMICIDAL AGENT; TENOFOVIR; UNCLASSIFIED DRUG;

CONDOM USE; DISEASE CONTROL; DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS; WOMENS HEALTH;

ANTIVIRAL ACTIVITY; BREAKTHROUGH BLEEDING; CLINICAL RESEARCH; CLINICAL TRIAL; CONDOM; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LOW DRUG DOSE; NONHUMAN; PETECHIA; REVIEW; SEXUALLY TRANSMITTED DISEASE; TOXICITY; UTERINE CERVICITIS; VAGINA DISEASE;

ADMINISTRATION, INTRAVAGINAL; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; NONOXYNOL; RANDOMIZED CONTROLLED TRIALS; SEXUAL BEHAVIOR; SPERMATOCIDAL AGENTS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 11144291464     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01338.x     Document Type: Review

References (67)

1. Amaral E, Perdigao A, Faundes A, Waller D & Zaneveld LJD (2002) Post-coital Testing and Vaginal Ecology after use of a Bio-adhesive Acid Buffering Gel (ACIDFORM) and a 2% Nonoxynol-9 Product. Microbicides, Antwerp, Belgium, Abstract no. B-136.
2. Ballagh S, Baker JM, Henry DM & Archer DF (2002) Safety of single daily use for one week of C31G HEC gel in women. Contraception 66, 369-375.
3. Bélec L, Tévi-Bénissan C, Bianchi A et al. (2000) In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. Journal of Antimicrobial Chemotherapy 46, 685-693.
4. Bourinbaiar AS & Fruhstorfer EC (1996) The efficacy of nonoxynol-9 from an in vitro point of view. AIDS 10, 558.
5. Bukenya M, Pickering J, Okong P, Byaruhanga R, Lacey CJN & Whitworth J (2002) A Phase II Study of the Safety of Dextrin Sulphate Gel in Sexually Active Females in Kampala. Microbicides, Antwerp, Belgium, Abstract no. B-025.
6. Coetzee N, Hoosen A, Blanchard K et al. (2002a) A Randomized, Placebo-controlled Double-blind Safety Trial of Carraguard® Microbicide Gel in South Africa: Signs and Symptoms of Genital Irritation. Microbicides, Antwerp, Belgium, Abstract no. B-069.
7. Coetzee N, Hoosen A, Blanchard K et al. (2002b) A Randomized, Placebo-controlled Double-blind Expanded Safety Trial of Carraguard® Microbicide Gel in South Africa: Signs and Symptoms of Genital Irritation. XIV International AIDS Conference, Barcelona, Spain, Abstract no. WeOrD1316.
8. Coggins C, Blanchard K, Alvarez F et al. (2000) Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sexually Transmitted Infections 76, 480-483.
9. Cook RL &c Rosenberg MJ (1998) Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? Sexually Transmitted Diseases 25, 144-150.
10. Doh A, Roddy R, Ngampoua F, Mcneil L, Nkele N & Lai J (2004) Phase 1 Multi-dose Safety and Acceptability Study of 6% Cellulose Sulfate (CS). Microbicides, London, UK, Abstract no. 02449.
11. Elias CJ, Coggins C, Alvarez F et al. (1997) Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception 56, 387-389.
12. Gaillard P, Mwanyumba F, Verhofstede C et al. (2001) Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS 15, 389-396.
13. Goeman J, Ndoye I, Sakho LM et al. (1995) Frequent use of Menfegol spermicidal vaginal foaming tablets associated with a high incidence of genital lesions. JID 171, 1611-1614.
14. Harrison C & Chantier E (1998) The effect of nonoxynol-9 and chlorhexidine on HIV and sperm in vitro. International Journal of STD and AIDS 9, 92-97.
15. Heise LL & Elias CJ (1995) Transforming AIDS prevention to meet women's needs: a focus on developing countries. Social Science and Medicine 40, 931-943.
16. Hicks DR, Martin LS, Getchell JP et al. (1985) Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. The Lancet 2, 1422-1423.
17. Hira SK, Feldblum PJ, Kamanga J, Mukelabai G, Weir SS & Thomas JC (1997) Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. International Journal of STD and AIDS 8, 243-250.
18. Kilmarx PH, Witwatwongwana P, van de Wijgert J et al. (2002) Incidence of Irritation and Genital Lesions in a Year-long, Randomized, Controlled Clinical Trial of a Carrageenan Gel as a Vaginal Microbicide. Microbicides, Antwerp, Belgium, Abstract no. B-227.
19. Kreiss J, Ngugi E, Holmes KK et al. (1992) Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 268, 477-482.
20. Lacey CJN, Mayer KH, Abdool Karim SS et al. (2002) Safety and Tolerance of PRO2000 gel, a Candidate Vaginal Microbicide, in Different Populations. XIV International AIDS Conference, Barcelona, Spain, Abstract no. MoPeD3652.
21. Latka M, Gollub EL, French P & Stein Z (2000) Male-condom and female-condom use among women after counseling in a risk-reduction hierarchy for STD prevention. Sexually Transmitted Diseases 27, 431-437.
22. Lesher JL Jr (1992) What's in a name when efficacy isn't efficacious? JAMA 268, 3434.
23. Limpakarnjanarat K, Kilmarx PH, van de Wijgert J et al. (2002) A Year-long, Randomized, Controlled Clinical Trial of a Carrageenan Gel as a Vaginal Microbicide: Incidence of Irritation and Genital Lesions. XIV International AIDS Conference, Barcelona, Spain, Abstract no. MoPeD3651.
24. Louv WC, Austin H, Alexander WJ, Stagno S & Cheeks J (1988) A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. The Journal of Infectious Diseases 58, 518-523.
25. Low-Beer N, Jespers V, McCormack S et al. (2001) A dose-ranging phase I/II study of dextrin sulphate gel as a novel vaginal microbicide: data from 50 HIV-negative women. International Journal of STD and AIDS 12 (Suppl. 2), 36.
26. Low-Beer N, Gabe R, McCormack S, Kitchen VS, Lacey CJN & Nunn AJ (2002a) Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners. Journal of Acquired Immune Deficiency Syndromes 31, 391-398.
27. Low-Beer N, Jespers V, McCormack S et al. (2002b) A Safety Study of Dextrin Sulphate Gel as a Novel Vaginal Microbicide: Data from HIV-negative and -positive Women. Microbicides, Antwerp, Belgium, Abstract no. B-095.
28. Low-Beer N, Jespers V, McCormack S et al. (2002c) A Safety Study of Dextrin Sulphate Gel as a Novel Vaginal Microbicide: Data from HIV-negative and -positive Women. XIV International AIDS Conference, Barcelona, Spain, Abstract no. WeOrD1317.
29. Malonza I, Mirembe F, Nakabiito C et al. (2004) Expanded Phase I Safety and Acceptability Trial of 6% Cellulose Sulphate Gel as a Vaginal Microbicide. Microbicides, London, UK, Abstract no. 02597.
30. Mauck C, Frezieres R, Walsh T, Robergeau K & Callahan M (2001a) Cellulose sulfate: tolerance and acceptability of penile application. Contraception 64, 377-381.
31. Mauck C, Weiner DH, Ballagh S et al. (200lb) Single and multiple exposure tolerance study of cellulose sulfate gel: a phase I safety and colposcopy study. Contraception 64, 383-391.
32. Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM & Bax R (2004a) A randomized phase I vaginal safety study of three concentrations of C31G vs. extra strength Gynol II. Contraception 70, 233-240.
33. Mauck CK, Frezieres RG, Walsh TL, Schmitz SW, Callahan MM & Bax R (2004b) Male tolerance study of 1% C31G. Contraception 70, 221-225.
34. Mauck CK, Creinin MD, Barnhart KT et al. (2004c) A phase I comparative post-coital testing study of three concentrations of C31G. Contraception 70, 227-231.
35. Mayer KH, Peipert J, Fleming T et al. (2001) Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clinical Infectious Diseases 32, 476-482.
36. Mayer KH, Abdool Karim SS, Kelly CW et al. (2003) Safety and tolerability of vaginal PRO2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS 17, 321-329.
37. Miller CJ, Hendricks AG, Alexander NJ, Marx PA & Gettie A (1992) The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertility and Sterility 57, 1126-1128.
38. New York State Department of Health AIDS Institute (1992) Methods of Personal Protection for Women to Reduce Transmission of HIV through Vaginal Intercourse. New York State Department of Health AIDS Institute, Policy Statement, January.
39. NIAID Workshop (2003) Summary: Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Protection. 12 and 13 June 2000. NIAID Workshop, Herndon, Virginia, USA. Webpage: http://www.niaid.nih.gov/ dmid/stds/ condomreport.pdf (accessed 27 October 2004).
40. Niruthisard S, Roddy RE & Chutivongse S (1991) The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sexually Transmitted Diseases 18, 176-179.
41. Niruthisard S, Roddy RE & Chutivongse S (1992) Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. The Lancet 339, 1371-1375.
42. Patton DL, Kidder GG, Sweeney YC, Rabe LK & Hillier SL (1999) Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemes trina). American Journal of Obstetrics and Gynecology 180, 1080-1087.
43. Polsky B, Baron PA, Gold JWM, Smith JL, Jensen RH & Armstrong D (1988) In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. The Lancet 1, 1456.
44. Roddy RE, Cordero M, Cordero C & Fortney JA (1993) A dosing study of nonoxynol-9 and genital irritation. International Journal of STD and AIDS 4, 165-170.
45. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS & Wong EL (1998) A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. The New England Journal of Medicine 339, 504-510.
46. Roddy RE, Zekeng L, Ryan KA, Tamoufe U & Tweedy KG (2002) Effect of nonoxynol-9 gel on urogenital gonorrhea and Chlamydia infection. A randomized controlled trial. JAMA 287, 1117-1122.
47. Rosenberg MJ & Gollub EL (1992) Methods women can use that may prevent sexually transmitted disease including HIV. AJPH 82, 1473-1478.
48. Rosenberg MJ, Rojanapithayakorn W, Feldblum PJ & Higgins JE (1997) Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. JAMA 257, 2308-2312.
49. Rottingen JA, Cameron DW & Garnett GP (2001) A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sexually Transmitted Diseases 28, 579-597.
50. Schwartz J, Mauck C, Lai J et al. (2004) Phase I 14-day Safety and Acceptability Study of 6% Cellulose Sulfate. Microbicides, London, UK, Abstract no. 02496.
51. Stafford MK, Cain D, Rosenstein I et al. (1997) Placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14, 213-218.
52. Stone KM & Peterson HB (1992) Spermicides, HIV, and the vaginal sponge. JAMA 268, 521-523.
53. Tabet SR, Callahan MM, Mauck CK et al. (2003) Safety and acceptability of penile application of two candidate topical microbicides, BufferGel™ and PRO2000 Gel: 3 randomized trials, in healthy low-risk men and HIV-positive men. Journal of AIDS 33, 476-483.
54. Taha ET, Biggar RJ, Broadhead RL et al. (1997) Effect of cleansing the birth canal with antiseptic solution on maternal and new-born morbidity and mortality in Malawi: clinical trial. BMJ 15, 216-220.
55. Tévi-Bénissan C, Makuva M, Morelli A et al. (2000) Protection of cynomolgus macaque against cetvicovaginal transmission of SIVmac251 by the spermicide benzalkonium chloride. J AIDS 24, 147-153.
56. UNAIDS (2003) Web site: http://www.unaids.org/EN/default.asp (accessed 27 October 2004).
57. Van Damme L, Niruthisard S, Atisook R et al. (1998) Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS 12, 433-437.
58. Van Damme L, Wright A, Depraetere K et al. (2000a) A phase I study of a novel potential intravaginal microbicide, PRO2000, in healthy sexually inactive women. Sexually Transmitted Infections 76, 126-130.
59. Van Damme L, Chandeying V, Ramjee G et al. (2000b) Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. AIDS 14, 85-88.
60. Van Damme L, Jespers V, Van Dyck E & Chapman A (2002a) Penile application of dextrin sulphate gel (Emelle). Contraception 66, 133-136.
61. Van Damme L, Ramjee G, Alary M et al. (2002b) COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. The Lancet 360, 971-977.
62. de Vincenzi I (1994) A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. NEJM 331, 341-346.
63. Wainberg MA, Spira B, Bleau G & Thomas R (1990) Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. Journal of Clinical Microbiology 28, 156-158.
64. Weir SS, Feldblum PJ, Zekeng L & Roddy RE (1994) The use of nonoxynol-9 for protection against cervical gonorrhea. American Journal of Public Health 84, 910-914.
65. van de Wijgert J, Fullem A, Kelly CW et al. (2001) Phase I trial of the topical microbicide BufferGel: safety results from four international sites. J AIDS 26, 21-27.
66. World Health Organization, Global Program on AIDS (1995) Manual for the Standardization of Colposcopy for the Evaluation of Vaginally Administered Products. WHO/GPA/RID/ CRD/95.10.
67. Zekeng L, Feldblum PJ, Oliver RM & Kaptue L (1993) Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 7, 725-731.